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The binding mode of telomestatin to G-quadruplex DNA has been investigated using electrospray mass spectrometry, by detecting
the intact complexes formed in ammonium acetate. The mass measurements show the incorporation of one extra ammonium ion
in the telomestatin complexes. Experiments on telomestatin alone also show that the telomestatin alone is able to coordinate
cations in a similar way as a crown ether. Finally, density functional theory calculations suggest that in the G-quadruplex-
telomestatin complex, potassium or ammonium cations are located between the telomestatin and a G-quartet. This study
underlines that monovalent cation coordination capabilities should be integrated in the rational design of G-quadruplex binding
ligands.
1.Introduction
The formation of G-quadruplex folds by telomeric DNA is
thought to play a role in telomere regulation. It has been
shown that G-quadruplex ligands binding speciﬁcally to the
telomeric G-quadruplex structure eﬀectively alter telomere
capping and cause the senescence or apoptosis of cancer cells
[1–5]. A variety of ligands have now been described as G-
quadruplex binders, but a key issue in ligand design is often
the speciﬁcity for G-quadruplexes over duplex sequences
[4, 6–8]. Identifying binding modes that make a ligand a
speciﬁc and highly active G-quadruplex binder is crucial for
the rational design of novel molecules.
Telomestatin (Figure 1) is one of the most emblematic
G-quadruplex ligands. The molecule was ﬁrst extracted
from Streptomyces anulatus 3533-SV4 [9]. It is highly
speciﬁc for G-quadruplexes, with no signiﬁcant binding
to duplexes [10–12]. Telomestatin was found to eﬀectively
inhibit the DNA binding of telomere-associated proteins
such as telomerase [13], POT1 and TRF2 [14], and even
Topo III in ALT cell lines [15]. It therefore induces telomere
shortening and apoptosis [16–19] not only via telomerase
inhibitionbutalsoviatelomereuncapping,andthereforehas
potential activity against many cancer cell types.
Telomestatin binds to G-quadruplexes, among which is
the human telomeric G-quadruplex, by external stacking
[12]. One G-quadruplex unit can therefore accommodate
twotelomestatinligands,oneoneachend.Arecentmodeling
study showed that telomestatin has a tendency to capture a
potassium ion, either from the G-quadruplex itself or from
the solution [20]. Here we show that mass spectrometry
provides experimental evidence for the accommodation of
one extra cation when a telomestatin molecule is bound to
a G-quadruplex. This will be illustrated for three typical G-
quadruplexes: the tetramolecular [TG4T]4 quadruplex, the
4-repeat telomeric sequence (T2AG3)4, and the Pu22myc
promoter sequence GAG3TG4AG3TG4A2G. The typical folds
adopted by each of these three G-quadruplexes in ammo-
nium acetate were studied previously [21–23]a n da r e
summarized in Figure 1.2 Journal of Nucleic Acids
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Figure 1: Chemical structure of telomestatin and folding pattern of the three G-quadruplexes studied here. [TG4T]4 adopts a parallel
fold and can incorporate three ammonium ions between its four G-quartets [21], the 4-repeat telomeric sequence (T2AG3)4 adopts an
intramolecular antiparallel fold in ammonium acetate and incorporates up to two ammonium ions [22], and the Pu22myc promoter
sequence GAG3TG4AG3TG4A2G adopts a predominantly parallel fold in ammonium acetate and incorporates two ammonium ions [23].
2.ExperimentalSection
2.1. Materials. A l lo l i g o n u c l e o t i d e sw e r ep u r c h a s e df r o m
Eurogentec (Seraing, Belgium), solubilized in water doubly
distilledinhouse,andthe400μMstocksolutionswerestored
at −20◦C. The solvents used include methanol (absolute,
HPLC grade, Biosolve, Valkenswaard, The Netherlands), bi-
distilled water, and aqueous ammonium acetate (5M stock
solution from Fluka, diluted with bi-distilled water). KCl
for the evaluation of the complexation of telomestatin alone
was puriss, p.a., ≥99.5% (T) (Fluka). G-quadruplexes were
formed by annealing (heating the oligonucleotides for 5
minutes at 85◦C, followed by slow cooling to room temper-
ature) in 150mM ammonium acetate. The G-quadruplex-
forming oligonucleotides were dTG4T (annealed at 200μM
single strand to form 50μM tetramolecular G-quadruplex);
thetelomericsequence(T2AG3)4 andthePu22mycpromoter
sequence GAG3TG4AG3TG4A2G (annealed at 50μM single
strand to form intramolecular G-quadruplexes). Telomes-
tatin was isolated and puriﬁed as described elsewhere [9, 24]
to obtain a 1mM stock solution in DMSO. For the electro-
spray mass spectrometry analysis of the complexes, the ﬁnal
injectedsolutionswere5μMinG-quadruplexand5to10μM
intelomestatin(only10μMresultsareshown),in80/20(v/v)
aqueous ammonium acetate (150mM)/methanol.
2.2. Mass Spectrometry. Electrospray mass spectrometry
experiments were performed on a Q-TOF Ultima Global
(Waters, Manchester, UK). The spectra of the intact
G-quadruplexes and their noncovalent complexes with
telomestatin were recorded in the negative ion mode
(capillary voltage = −2.2V, source and desolvation
temperatures = 70◦C, cone = 100V, RF Lens1 Energy =
45V, source pirani pressure = 3.94mbar, collision energy
= 10V), smoothed (mean function, 3 × 20 channels) and
subtracted (polynomial order 99, 0.1% below curve). The
spectra of telomestatin in the absence of G-quadruplex
were recorded in the positive ion mode (capillary voltage
= +2.8V, source and desolvation temperatures = 80 and
100◦C, resp., cone = 100V, RF Lens1 Energy = 50V, source
pirani pressure = 3.33mbar and collision energy = 7V)and
were not subjected to smoothing or background subtraction.
2.3. Calculations. For the [telomestatin + cation] binary
complexes, the ammonium, potassium, and sodium cations
were manually docked within the telomestatin ring, and the
resulting structures were optimized using density functional
theory (DFT) with the hybrid functional B3LYP and the
6-31G(d,p) basis set. For the ternary complexes between
[telomestatin + cation + one G-quartet], the telomestatin
was manually docked on top of an optimized structure
of a G-quartet coordinated with the cation (ammonium,
potassium, sodium). The ternary complexes were then
optimized using DFT B3LYP at the 6-31G(d,p) level. All
electronic structure calculations were performed using the
Gaussian 03 rev. D.02 software suite [25]. Comparison with
a larger basis set (6-311 + G(d,p)) was performed for one
of the complexes (G-tetrad + K + telomestatin), and the
results were similar in terms of both energies (0.8kcal/mol)
and geometries (RMSD 0.16
 
˚ A). 6-31G(d,p) basis set was
therefore used for all calculations. Other hybrid functional
BHandHLYP and new meta-GGA hybrid MPWB1K [26]
have also been tested for comparison with B3LYP.
3. Results and Discussion
When operated in soft source conditions, electrospray mass
spectrometry allows detecting intact noncovalent complexes
[27–30]. In the analysis of quadruplex-ligand complexes,
it therefore allows determining the number of strands, the
number of ligands, and the number of cations in each
complex. Electrospray mass spectrometry of nucleic acid
noncovalentcomplexesistypicallyperformedinammonium
acetate solution in order to obtain clean spectra [31].
Ammonium ions present in the counter-ion shell around
phosphates are lost during the ﬁnal stages of desolva-
tion in the electrospray source, even in soft conditionsJournal of Nucleic Acids 3
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Figure 2: Negative ion mode electrospray mass spectra of mixtures of 10μM telomestatin and 5μM of G-quadruplexes. Zooms on the
peaks of free G-quadruplex (a) [TG4T]4, (b) telomeric sequence (T2AG3)4, and (c) Pu22myc promoter sequence GAG3TG4AG3TG4A2G,
and on the complexes between (d) one telomestatin and [TG4T]4, (e) one telomestatin and (T2AG3)4, and (f) one telomestatin and
GAG3TG4AG3TG4A2G. The spectra were recorded from and 80/20 aqueous ammonium acetate (150mM)/methanol solution, using soft
source conditions to preserve the speciﬁcally bound ammonium ions.
(low acceleration voltages). In contrast, ammonium ions
bound suﬃciently tightly to the G-quadruplex, such as
the ammonium ions trapped between the G-quartets, will
persist at higher acceleration voltages in the source than the
nonspeciﬁcally bound ones [21].
Figure 2 shows the electrospray mass spectra of three
typical G-quadruplexes: (a) [TG4T]4, (b) the telomeric
sequence(T2AG3)4,and(c)thePu22mycpromotersequence
GAG3TG4AG3TG4A2G and on their 1:1 complexes with
telomestatin (d–f, resp.). The injected mixtures are 5μMi n
each G-quadruplex 10μM in telomestatin, in 80/20 aqueous
ammonium acetate (150mM)/methanol, and the spectra
were recorded using soft source conditions to preserve the
speciﬁcally bound ammonium ions. The free [TG4T]4 G-
quadruplex (Figure 2(a)) contains three ammonium ions:
the 5− charge state is found at m/z = 1500.22, correspond-
ing to [Q ·(NH+
4)3]
5−. The major peaks of the telomeric
(Figure 2(b)) and Pu22myc (Figure 2(c)) G-quadruplexes at
charge state 5− are corresponding to the intramolecular G-
quadruplex with two ammonium ions, at (m/z) = 1521.22
and 1419.47, respectively. For the charge state z = 5, with
the average mass of telomestatin being m = 582.5Da, the4 Journal of Nucleic Acids
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Figure 3: Positive ion mode electrospray mass spectra of 15μM telomestatin (a) in 80/20 water/methanol, (b) in 80/20 water methanol and
5μM ammonium acetate, and (c) in 80/20 water methanol and 5μM potassium chloride.
Δ(m/z) between the G-quadruplex and its complex with one
telomestatin, with no change in the amount of ammonium
ions incorporated, is expected to be equal to 582.5/5 =
116.5. In contrast, the observed Δ(m/z) between the major
peak of the quadruplex and the major peak of its complex
with one ligand is equal to 119.9 (compare Figure 2(a) with
Figure 2(d), and Figure 2(b) with Figure 2(e), Figure 2(c)
with Figure 2(f)). This corresponds to the addition of one
telomestatin molecule, one extra ammonium ion, and the
subtraction of one proton for the charge balance (119.9 =
(585.5 + 18−1)/5). The complex with one telomestatin lig-
and therefore systematically contains one more ammonium
ion than the corresponding unbound G-quadruplex. This
extra ammonium ion is lost when the acceleration voltage
is increased.
In our previous report on the MS detection of telomes-
tatin binding to telomeric DNA [11], we have missed this
“extra ammonium” for two reasons. Firstly, for the 3.5-
repeat telomeric sequence studied previously it is diﬃcult
to preserve two inner ammoniums even in soft conditions.
Secondly, soft conditions could not be used because a long
duplex had to be detected simultaneously with the G-strand,
and the electrospray source conditions were chosen as a
compromise.
Electrospray mass spectrometry is also powerful to ana-
lyze caged supramolecular complexes such as crown ethers
bound to cations [32–35]. To probe whether telomestatin
is able to coordinate a cation already in the absence of
G-quadruplex, we used ESI-MS in the positive ion mode
on telomestatin solutions. Figure 3(a) shows the spectrum
obtained with telomestatin dilution in bi-distilled water. The
signal-to-noise ratio of all peaks is weak, indicating low
protonation and cationization eﬃciencies. Surprisingly, we
found that the major peak was a doubly charged ion at m/z
= 686.1 (base peak), whose isotopic distribution matches
with that of a complex between two telomestatin ligands
and one lead ion adduct. The fragment ion spectrum shows
the loss of one telomestatin, and the isotopic distribution
of the resulting [Telomestatin + Pb] complex conﬁrms the
presence of lead. Traces of lead come from the puriﬁcation
of telomestatin from Streptomyces anulatus 3533-SV4 [24].
Another weak doubly charged peak is tentatively assigned to
acomplexbetweentwotelomestatinandtwoH3O+ ions,and
the fragment ion spectrum shows only the singly protonated
telomestatin.
We then doped the solution with either ammonium
acetate or with potassium chloride, in substoichiometric
amounts, to probe if telomestatin was able to coordinateJournal of Nucleic Acids 5
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Figure 4: Optimized geometries (DFT B3LYP, 6-31G(d,p)) of the telomestatin—cation complexes (side view) for (a) NH
+
4,( b )K
+, and (c)
Na
+, and optimized geometries of the telomestatin—cation—G-quartet complexes (top view and side view) for (d) NH
+
4,( e )K
+, and (f)
Na
+. Telomestatin is shown in yellow, the cation is shown in purple, and the G-quartet is colored by elements.
monovalent cations such as those typically coordinated to
G-quartets. In the presence of ammonium ions, the lead
complex totally disappears and the complex [telomestatin +
NH+
4]i sd e t e c t e da tm/z = 600. In the presence of potassium
ions, the complex [telomestatin + K+]i sd e t e c t e da tm/z =
621, but the lead complex has not disappeared completely.
All experimental results suggest that telomestatin has
signiﬁcant aﬃnity for monovalent cations like the ammo-
nium ion, and this could inﬂuence its binding mode to
the G-quadruplex DNA. We performed DFT calculations
in order to ascertain the possible coordination geometries
of the monovalent cations to telomestatin. The geometries
of the [telomestatin + cation] binary complexes are shown
in Figures 4(a)–4(c), and the geometries of the ternary
complexes between [telomestatin + cation + one G-quartet]
are shown in Figures 4(d)–4(f). In the isolated [telomestatin
+ cation] complexes, all cations are coordinated in the plane
of the telomestatin. In the ternary complexes with the G-
quartet, the cation clearly moves towards the G-quartet.
The structures of the complexes with K+ and NH+
4 are
similar, with the cation coordinated midway between the
telomestatin and the G-quartet. Sodium, on the other hand,
sits closer to the G-quartet than to the telomestatin.
The mode of cation coordination to the telomestatin—
G-quartet system is similar to the coordination mode
already described for successive G-quartets [36]. In terms
of coordination geometries, potassium tends to sit between
G-quartets while sodium tends to ﬁt in the middle of
one G-quartet because it is smaller. K+ and NH+
4 have
similar ionic radii [37, 38] and therefore behave similarly,
and the same trend is observed for our telomestatin-G-
quartet complex. The optimized geometries are similar for
all functionals tested (B3LYP, BHandHLYP, MPBW1K) (see
Figure S1 in Supplementary Material available online at
doi: 10.4061/2010/121259), with the cation in the plane
of telomestatin in the absence of G-quartet, and between
telomestatin and the G-quartet in the ternary complex.
However, the functionals have a greater inﬂuence on the
computed interaction energies. The root mean square dis-
tances (RMSDs) for two-by-two comparisons of hybrid
functional, and the interaction energies of NH+
4,K + and Na+
with telomestatin alone, telomestatin + one G-quartet are
given in supplementary Tables S1 and S2, respectively.
4. Conclusion
We have therefore shown that telomestatin readily coor-
dinates monovalent cations such as K+ and NH+
4,a n d
that telomestatin retains this cation while binding to G-
quadruplexes. The observed stoichiometry and the calcula-
tions are consistent with a cation trapped midway between
the telomestatin and the G-quartet. Telomestatin therefore
acts like an analog of a G-quartet. This study underlines
that monovalent cation coordination capabilities should be6 Journal of Nucleic Acids
integrated in the rational design of G-quadruplex binding
ligands.
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